Tweet
ThirdAge
<img alt="" height="1" width="1" />
FDA approves Gilead-J&J HIV pill Complera
BusinessWeek
The Food and Drug Administration has approved a once-per-day HIV treatment that combines its Gilead Sciences Inc.'s drug Truvada with Johnson & Johnson's drug Edurant, Gilead said Wednesday. The combination pill is called Complera, and it is approved ...
Ahead of the Bell: Analyst sees low Complera hopesForbes
FDA approves Gilead's Single-Tablet Triple HIV Therapy ComplereGenetic Engineering News
FDA Okays Another Once-Daily HIV PillMedPage Today
Bloomberg -Wall Street Journal -Medscape
all 83 news articles »
More...